Drugmaker Investment in New Manufacturing Plants Is ‘Real Solution’ to Shortages: FDA Official

The FDA is calling on drugmakers to build new manufacturing plants as part of their contribution to preventing drug shortages. While early notification from industry has helped the FDA prevent or lessen some shortages, new manufacturing facilities is “the real solution,” CDER’s Office of New Drugs Deputy Director Sandra Kweder said.
Drug Industry Daily